Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.

Sho ShimohamaToshiki TezukaTakahata KeisukeShogyoku BunHajime TabuchiMorinobu SekiYuki MomotaNatsumi SuzukiAyaka MorimotoYu IwabuchiMasahito KubotaYasuharu YamamotoYasunori SanoRyo ShikimotoKei FunakiYu MimuraYoshinori NishimotoRyo UedaMasahiro JinzakiJin NakaharaMasaru MimuraDaisuke Ito

Published in: Neurology (2022)

This study provides Class I evidence that the combination of amyloid and tau PETs was associated with changes in management and diagnosis of MCI and dementia.

Keyphrases

mild cognitive impairment
cerebrospinal fluid
computed tomography
pet ct
cognitive impairment